Brokers Offer Predictions for Medical Properties Trust, Inc.’s Q1 2022 Earnings (NYSE:MPW)

Medical Properties Trust, Inc. (NYSE:MPW – Get Rating) – Investment analysts at Jefferies Financial Group dropped their Q1 2022 earnings estimates for Medical Properties Trust in a report released on Thursday, April 14th. Jefferies Financial Group analyst J. Petersen now expects that the real estate investment trust will post earnings per share of $0.46 for the quarter, down from their previous forecast of $0.47. Jefferies Financial Group also issued estimates for Medical Properties Trust’s Q2 2022 earnings at $0.46 EPS, FY2022 earnings at $1.84 EPS, Q1 2023 earnings at $0.46 EPS, Q2 2023 earnings at $0.47 EPS, Q3 2023 earnings at $0.47 EPS, FY2023 earnings at $1.89 EPS and FY2024 earnings at $1.93 EPS.

Medical Properties Trust (NYSE:MPW – Get Rating) last posted its quarterly earnings data on Thursday, February 3rd. The real estate investment trust reported $0.34 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.12). Medical Properties Trust had a net margin of 42.47% and a return on equity of 7.83%. The company had revenue of $409.30 million for the quarter, compared to the consensus estimate of $403.73 million. During the same period last year, the business earned $0.41 EPS. The firm’s quarterly revenue was up 22.6% on a year-over-year basis.

A number of other equities analysts also recently issued reports on MPW. StockNews.com assumed coverage on Medical Properties Trust in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. Truist Financial lowered their target price on Medical Properties Trust from $26.00 to $23.00 and set a “hold” rating on the stock in a research report on Thursday, March 24th. Mizuho lifted their target price on Medical Properties Trust from $23.00 to $26.00 in a research report on Thursday, January 20th. Credit Suisse Group lowered their target price on Medical Properties Trust from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, February 14th. Finally, Deutsche Bank Aktiengesellschaft downgraded Medical Properties Trust from a “buy” rating to a “hold” rating and lowered their target price for the company from $27.00 to $25.00 in a research report on Monday, January 3rd. Five equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $24.00.

MPW stock opened at $20.23 on Friday. The company has a market cap of $12.06 billion, a P/E ratio of 18.39, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. Medical Properties Trust has a 1 year low of $19.39 and a 1 year high of $24.13. The company has a debt-to-equity ratio of 1.34, a current ratio of 3.99 and a quick ratio of 3.99. The stock’s fifty day moving average price is $20.65 and its 200-day moving average price is $21.43.

The company also recently declared a quarterly dividend, which was paid on Thursday, April 14th. Investors of record on Thursday, March 17th were issued a $0.29 dividend. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.28. The ex-dividend date was Wednesday, March 16th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 5.73%. Medical Properties Trust’s payout ratio is presently 105.45%.

In other Medical Properties Trust news, CFO R Steven Hamner sold 285,000 shares of the company’s stock in a transaction on Thursday, April 7th. The stock was sold at an average price of $21.04, for a total transaction of $5,996,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Edward K. Aldag, Jr. sold 615,000 shares of the company’s stock in a transaction on Wednesday, March 30th. The stock was sold at an average price of $21.33, for a total value of $13,117,950.00. The disclosure for this sale can be found here. Insiders sold 906,000 shares of company stock valued at $19,235,910 in the last quarter. 1.04% of the stock is owned by company insiders.

Several hedge funds have recently modified their holdings of the company. BlackRock Inc. increased its position in shares of Medical Properties Trust by 0.9% during the fourth quarter. BlackRock Inc. now owns 82,216,544 shares of the real estate investment trust’s stock worth $1,942,776,000 after purchasing an additional 711,240 shares in the last quarter. State Street Corp increased its position in shares of Medical Properties Trust by 26.1% in the 4th quarter. State Street Corp now owns 32,358,616 shares of the real estate investment trust’s stock valued at $772,143,000 after acquiring an additional 6,702,693 shares during the period. Principal Financial Group Inc. increased its position in shares of Medical Properties Trust by 1.9% in the 4th quarter. Principal Financial Group Inc. now owns 20,822,929 shares of the real estate investment trust’s stock valued at $490,158,000 after acquiring an additional 379,862 shares during the period. Bank of New York Mellon Corp increased its position in shares of Medical Properties Trust by 17.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 15,172,459 shares of the real estate investment trust’s stock valued at $304,512,000 after acquiring an additional 2,233,068 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of Medical Properties Trust by 3.0% in the 4th quarter. Geode Capital Management LLC now owns 9,163,551 shares of the real estate investment trust’s stock valued at $216,255,000 after acquiring an additional 269,485 shares during the period. 80.77% of the stock is currently owned by institutional investors and hedge funds.

About Medical Properties Trust (Get Rating)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis.

Featured Stories